Key result
Long-term administration of captopril in patients with left ventricular dysfunction post-myocardial infarction improved survival and reduced major cardiovascular events.
Why the study?
Does long-term administration of captopril improve survival and reduce cardiovascular morbidity and mortality in patients with asymptomatic left ventricular dysfunction after myocardial infarction?
Does long-term administration of captopril improve survival and reduce cardiovascular morbidity and mortality in patients with asymptomatic left ventricular dysfunction after myocardial infarction?
Long-term captopril therapy improves survival and reduces major cardiovascular events in patients with asymptomatic left ventricular dysfunction post-myocardial infarction.
Answers are grounded in this paper and cite their sources.
Long-term captopril indicated for asymptomatic LV dysfunction post-MI; confirms and extends ACE inhibitor benefits beyond symptomatic HF.
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events. These benefits were observed in patients who received thrombolytic therapy, aspirin, or beta-blockers, as well as those who did not, suggesting that treatment with captopril leads to additional improvement in outcome among selected survivors of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Pfeffer et al. (1992) studied this question. Long-term administration of captopril in patients with left ventricular dysfunction post-myocardial infarction improved survival and reduced major cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: